• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Developing a Novel Combination Therapy and Elucidating Mechanisms of Increased ALT-NHEJ in Acute Myeloid Leukemia

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Muvarak_umaryland_0373D_10859.pdf
    Size:
    6.962Mb
    Format:
    PDF
    Download
    Author
    Muvarak, Nidal Emilio
    Advisor
    Rassool, Feyruz V.
    Date
    2017
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that results from a differentiation block of hematopoietic stem/progenitor cells, leading to accumulation of myeloblasts in the bone marrow. Frontline chemotherapy has a 22% survival rate, with rapid relapse occurring particularly in poor-response subgroups such as those patients bearing the FLT3/ITD mutation. While DNA methyltransferase inhibitors (DNMTis) are now second-line therapy in AML patients who have relapsed or are refractory to chemotherapy, treatment responses are not durable. This emphasizes the need for devising novel therapies for AML. Poly (ADP-ribose) polymerase (PARP) has been shown to bind DNMTs in response to DNA damage, and we reasoned that PARP inhibitors (PARPis) that are in use clinically could potentially enhance the DNMTi response. We showed that combination of DNMTi (decitabine) and PARPi (talazoparib) resulted in enhanced cytotoxicity in AML cell lines and primary AML samples relative to each drug alone. We found that the increased efficacy of this combination was due to enhanced PARP-DNA complexes, resulting in increased cytotoxic double-strand breaks. The efficacy of this combination was corroborated in two in vivo mouse models of AML. In a second study, we investigated the regulation of a highly error-prone form of non-homologous end-joining (NHEJ), alternative-NHEJ (ALT-NHEJ), in FLT3/ITD-positive AML. Our laboratory had previously shown that DNA ligase 3α (LIG3) and PARP1 (components of ALT-NHEJ pathway) are highly expressed in FLT3/ITD-positive AML. In this study, we demonstrated that c-MYC bound the promoters of LIG3 and PARP1, leading to their increased expression. Furthermore, c-MYC repressed microRNAs (miR-150 and miR-22) that regulate these two proteins at the post-transcriptional level. Importantly, inhibition of c-MYC or overexpression of miR-22 and miR-150 lead to a significant decrease in ALT-NHEJ activity. Taken together, we elucidated a mechanism by which ALT-NHEJ activity is amplified in AML, and exploited the upregulation of PARP1 as a target that enhanced the efficacy of the DNMTi-PARPi combination. Notably, our pre-clinical studies led to the launch of a Phase I/II clinical trial for testing decitabine-talazoparib combination therapy in refractory/relapsed AML. Results from this trial could lay the groundwork for similar trials in other cancers.
    Description
    University of Maryland, Baltimore. Toxicology. Ph.D. 2017
    Keyword
    DNA methyltransferase inhibitors
    combination therapy
    Leukemia, Myeloid, Acute--therapy
    DNA End-Joining Repair
    Poly(ADP-ribose) Polymerase Inhibitors
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/6733
    Collections
    Theses and Dissertations School of Medicine
    Theses and Dissertations All Schools

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.